Mirae Asset Global Investments Co., Ltd. Caribou Biosciences, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$20 Billion
Q2 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,696 shares of CRBU stock, worth $5,715. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,696

Previous 230,192 98.83%

Holding current value

$5,715

Previous $1.18 Million 99.66%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$1.62 - $5.05 $368,543 - $1.15 Million	-227,496 Reduced 98.83%	2,696 $4,000
Q1 2024 May 01, 2024	BUY	$4.82 - $8.26 $272,744 - $467,400	56,586 Added 32.59%	230,192 $1.18 Million
Q4 2023 Jan 24, 2024	SELL	$3.58 - $6.25 $423,460 - $739,281	-118,285 Reduced 40.52%	173,606 $994,000
Q3 2023 Oct 26, 2023	BUY	$4.08 - $8.14 $164,105 - $327,407	40,222 Added 15.98%	291,891 $1.4 Million
Q2 2023 Aug 10, 2023	BUY	$4.04 - $5.47 $114,865 - $155,523	28,432 Added 12.74%	251,669 $1.07 Million
Q1 2023 May 04, 2023	BUY	$4.3 - $7.78 $45,519 - $82,359	10,586 Added 4.98%	223,237 $1.19 Million
Q4 2022 Feb 09, 2023	SELL	$5.57 - $11.01 $217,113 - $429,158	-38,979 Reduced 15.49%	212,651 $1.34 Million
Q3 2022 Nov 10, 2022	BUY	$5.34 - $12.79 $176,033 - $421,622	32,965 Added 15.08%	251,630 $2.66 Million
Q2 2022 Jul 26, 2022	BUY	$5.1 - $9.74 $344,250 - $657,450	67,500 Added 44.65%	218,665 $1.19 Million
Q1 2022 Jun 02, 2022	BUY	$8.42 - $15.32 $1.27 Million - $2.32 Million	151,165 New	151,165 $1.39 Million
Q1 2022 May 10, 2022	SELL	$8.42 - $15.32 $1.51 Million - $2.74 Million	-178,913 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$14.59 - $23.26 $2.61 Million - $4.16 Million	178,913 New	178,913 $2.7 Million

Others Institutions Holding CRBU

# of Institutions

145

Shares Held

53.7M

Call Options Held

32.5K

Put Options Held

89.8K

View Full List

About Caribou Biosciences, Inc.

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $129M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

More about CRBU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Caribou Biosciences, Inc. Transaction History